Correlation Between Direxion Work and IShares Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Direxion Work and IShares Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Direxion Work and IShares Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Direxion Work From and iShares Genomics Immunology, you can compare the effects of market volatilities on Direxion Work and IShares Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Direxion Work with a short position of IShares Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Direxion Work and IShares Genomics.

Diversification Opportunities for Direxion Work and IShares Genomics

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Direxion and IShares is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Direxion Work From and iShares Genomics Immunology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Genomics Imm and Direxion Work is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Direxion Work From are associated (or correlated) with IShares Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Genomics Imm has no effect on the direction of Direxion Work i.e., Direxion Work and IShares Genomics go up and down completely randomly.

Pair Corralation between Direxion Work and IShares Genomics

Considering the 90-day investment horizon Direxion Work From is expected to generate 0.82 times more return on investment than IShares Genomics. However, Direxion Work From is 1.22 times less risky than IShares Genomics. It trades about 0.27 of its potential returns per unit of risk. iShares Genomics Immunology is currently generating about 0.02 per unit of risk. If you would invest  6,001  in Direxion Work From on August 31, 2024 and sell it today you would earn a total of  463.00  from holding Direxion Work From or generate 7.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Direxion Work From  vs.  iShares Genomics Immunology

 Performance 
       Timeline  
Direxion Work From 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Direxion Work From are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating technical and fundamental indicators, Direxion Work demonstrated solid returns over the last few months and may actually be approaching a breakup point.
iShares Genomics Imm 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Genomics Immunology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, IShares Genomics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Direxion Work and IShares Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Direxion Work and IShares Genomics

The main advantage of trading using opposite Direxion Work and IShares Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Direxion Work position performs unexpectedly, IShares Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Genomics will offset losses from the drop in IShares Genomics' long position.
The idea behind Direxion Work From and iShares Genomics Immunology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities